» Authors » Geetika Nehra

Geetika Nehra

Explore the profile of Geetika Nehra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nehra G, Maloney B, Smith R, Chumboatong W, Abner E, Nelson P, et al.
Fluids Barriers CNS . 2025 Jan; 22(1):4. PMID: 39789614
Background: Blood-brain barrier dysfunction is one characteristic of Alzheimer's disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal...
2.
Nehra G, Promsan S, Yubolphan R, Chumboatong W, Vivithanaporn P, Maloney B, et al.
Fluids Barriers CNS . 2024 Mar; 21(1):29. PMID: 38532486
Background: Patients with Alzheimer's disease (AD) develop blood-brain barrier dysfunction to varying degrees. How aging impacts Aβ pathology, blood-brain barrier function, and cognitive decline in AD remains largely unknown. In...
3.
Sziraki A, Zhong Y, Neltner A, Niedowicz D, Rogers C, Wilcock D, et al.
Neuropathol Appl Neurobiol . 2023 Oct; 49(6):e12942. PMID: 37812061
Aims: We sought to identify and optimise a universally available histological marker for pericytes in the human brain. Such a marker could be a useful tool for researchers. Further, identifying...
4.
Holder B, Tolan S, Heinrich K, Miller K, Hudson N, Nehra G, et al.
Fluids Barriers CNS . 2022 Mar; 19(1):19. PMID: 35232464
Background: Scientific conferences are vital communication events for scientists in academia, industry, and government agencies. In the brain barriers research field, several international conferences exist that allow researchers to present...
5.
Nehra G, Bauer B, Hartz A
Pharmacol Ther . 2022 Feb; 234:108119. PMID: 35108575
Alzheimer's disease (AD) is the most common form of dementia. AD brain pathology starts decades before the onset of clinical symptoms. One early pathological hallmark is blood-brain barrier dysfunction characterized...
6.
Nehra G, Andrews S, Rettig J, Gould M, Haag J, Howard S, et al.
Sci Rep . 2021 Mar; 11(1):6351. PMID: 33737566
Perillyl alcohol (POH) has been extensively studied for the treatment of peripheral and primary brain tumors. The intranasal route of administration has been preferred for dosing POH in early-stage clinical...
7.
Yanckello L, Hoffman J, Chang Y, Lin P, Nehra G, Chlipala G, et al.
Nutr Neurosci . 2021 Mar; 25(8):1669-1679. PMID: 33666538
Objective: The goal of the study was to identify the potential nutrigenetic effects to inulin, a prebiotic fiber, in mice with different human apolipoprotein E (APOE) genetic variants. Specifically, we...
8.
Kumar N, Pizzo M, Nehra G, Wilken-Resman B, Boroumand S, Thorne R
Bioconjug Chem . 2018 Sep; 29(12):3937-3966. PMID: 30265523
Passive immunotherapy, i.e., the administration of exogenous antibodies that recognize a specific target antigen, has gained significant momentum as a potential treatment strategy for several central nervous system (CNS) disorders,...
9.
Kumar N, Lochhead J, Pizzo M, Nehra G, Boroumand S, Greene G, et al.
J Control Release . 2018 Aug; 286:467-484. PMID: 30081144
The intranasal route has been hypothesized to circumvent the blood-brain and blood-cerebrospinal fluid barriers, allowing entry into the brain via extracellular pathways along olfactory and trigeminal nerves and the perivascular...